Literature DB >> 17943286

Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.

Sofia Lionaki1, J Charles Jennette, Ronald J Falk.   

Abstract

Anti-neutrophil cytoplasmic autoantibodies (ANCA) and anti-glomerular basement membrane (GBM) necrotizing and crescentic glomerulonephritis are aggressive and destructive glomerular diseases that are associated with and probably caused by circulating ANCA and anti-GBM antibodies. These necrotizing lesions are manifested by acute nephritis and deteriorating kidney function often accompanied by distinctive clinical features of systemic disease. Prompt diagnosis requires clinical acumen that allows for the prompt institution of therapy aimed at removing circulating autoantibodies and quelling the inflammatory process. Continuing exploration of the etiology and pathogenesis of these aggressive inflammatory diseases have gradually uncovered new paradigms for the cause of and more specific therapy for these particular glomerular disorders and for autoimmune glomerular diseases in general.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943286     DOI: 10.1007/s00281-007-0093-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  130 in total

Review 1.  Primary systemic vasculitis.

Authors:  C O Savage; L Harper; D Adu
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

2.  Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

Authors:  Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; E Christiaan Hagen; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 10.121

3.  Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.

Authors:  Maria Koukoulaki; David R W Jayne
Journal:  Nephron Clin Pract       Date:  2005-11-10

4.  C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.

Authors:  M E Griffith; J U Lovegrove; G Gaskin; D B Whitehouse; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1996-03       Impact factor: 5.992

5.  Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.

Authors:  Dennis Huugen; Hong Xiao; Anita van Esch; Ronald J Falk; Carine J Peutz-Kootstra; Wim A Buurman; Jan Willem Cohen Tervaert; J Charles Jennette; Peter Heeringa
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

6.  Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement.

Authors:  Priya J Bansal; Mary C Tobin
Journal:  Ann Allergy Asthma Immunol       Date:  2004-10       Impact factor: 6.347

7.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

8.  Membrane proteinase 3 expression and ANCA-induced neutrophil activation.

Authors:  Adrian Schreiber; Friedrich C Luft; Ralph Kettritz
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

9.  Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study.

Authors:  Susan L Hogan; Glinda S Cooper; David A Savitz; Leena A Nylander-French; Christine G Parks; Hyunsook Chin; Caroline E Jennette; Sofia Lionaki; J Charles Jennette; Ronald J Falk
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

10.  FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity.

Authors:  Manuela Fanciulli; Penny J Norsworthy; Enrico Petretto; Rong Dong; Lorraine Harper; Lavanya Kamesh; Joanne M Heward; Stephen C L Gough; Adam de Smith; Alexandra I F Blakemore; Philippe Froguel; Catherine J Owen; Simon H S Pearce; Luis Teixeira; Loic Guillevin; Deborah S Cunninghame Graham; Charles D Pusey; H Terence Cook; Timothy J Vyse; Timothy J Aitman
Journal:  Nat Genet       Date:  2007-05-21       Impact factor: 38.330

View more
  13 in total

Review 1.  Microscopic polyangiitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Rheum Dis Clin North Am       Date:  2010-06-11       Impact factor: 2.670

2.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

Review 3.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

4.  Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

Authors:  A Scott McCall; Gautam Bhave; Vadim Pedchenko; Jacob Hess; Meghan Free; Dustin J Little; Thomas P Baker; William F Pendergraft; Ronald J Falk; Stephen W Olson; Billy G Hudson
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

5.  Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.

Authors:  Neelakshi R Jog; Joudy-Ann Dinnall; Stefania Gallucci; Michael P Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

6.  Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome.

Authors:  Christoph Etter; Ariana Gaspert; Stephan Regenass; Rudolf P Wüthrich; Thomas Kistler; Renate Kain; Clemens D Cohen
Journal:  BMC Nephrol       Date:  2011-06-08       Impact factor: 2.388

Review 7.  Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review.

Authors:  Radovan Bogdanović; Predrag Minić; Jasmina Marković-Lipkovski; Nataša Stajić; Nataša Savić; Milan Rodić
Journal:  BMC Nephrol       Date:  2013-03-22       Impact factor: 2.388

8.  Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

Authors:  Sheena Surindran; Rivka Ayalon; Nazia Hasan; Laurence H Beck; David J Salant; Laura Barisoni; Edward Y Skolnik; Lada Beara-Lasic
Journal:  Clin Kidney J       Date:  2012-03-09

9.  Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies.

Authors:  Tariq Javed; Parag Vohra
Journal:  Case Rep Nephrol       Date:  2012-02-26

10.  Lutheran/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice.

Authors:  Jin Huang; Anne Filipe; Cécile Rahuel; Philippe Bonnin; Laurent Mesnard; Coralie Guérin; Yu Wang; Caroline Le Van Kim; Yves Colin; Pierre-Louis Tharaux
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.